[HTML][HTML] Biomarker discovery for personalized therapy selection in inflammatory bowel diseases: challenges and promises
D Alsoud, S Vermeire, B Verstockt - Current Research in Pharmacology …, 2022 - Elsevier
The past decades witnessed a significant stride in deciphering the pathophysiology of
inflammatory bowel disease, which further advanced drug development adding several new …
inflammatory bowel disease, which further advanced drug development adding several new …
[HTML][HTML] Biomarker discovery for personalized therapy selection in inflammatory bowel diseases: Challenges and promises
D Alsoud, S Vermeire, B Verstockt - Current Research in …, 2022 - ncbi.nlm.nih.gov
The past decades witnessed a significant stride in deciphering the pathophysiology of
inflammatory bowel disease, which further advanced drug development adding several new …
inflammatory bowel disease, which further advanced drug development adding several new …
Biomarker discovery for personalized therapy selection in inflammatory bowel diseases: Challenges and promises.
D Alsoud, S Vermeire, B Verstockt - Current Research in …, 2022 - europepmc.org
The past decades witnessed a significant stride in deciphering the pathophysiology of
inflammatory bowel disease, which further advanced drug development adding several new …
inflammatory bowel disease, which further advanced drug development adding several new …
Biomarker discovery for personalized therapy selection in inflammatory bowel diseases: Challenges and promises
D Alsoud, S Vermeire… - Current research in …, 2022 - pubmed.ncbi.nlm.nih.gov
The past decades witnessed a significant stride in deciphering the pathophysiology of
inflammatory bowel disease, which further advanced drug development adding several new …
inflammatory bowel disease, which further advanced drug development adding several new …
[PDF][PDF] Current Research in Pharmacology and Drug Discovery
D Alsoud, S Vermeire, B Verstockt - lirias.kuleuven.be
The past decades witnessed a significant stride in deciphering the pathophysiology of
inflammatory bowel disease, which further advanced drug development adding several new …
inflammatory bowel disease, which further advanced drug development adding several new …
Biomarker discovery for personalized therapy selection in inflammatory bowel diseases: Challenges and promises.
D Alsoud, S Vermeire, B Verstockt - Current Research in …, 2022 - europepmc.org
The past decades witnessed a significant stride in deciphering the pathophysiology of
inflammatory bowel disease, which further advanced drug development adding several new …
inflammatory bowel disease, which further advanced drug development adding several new …